Skip to content
Vensana

Vensana

  • Our Team
  • Values
  • Our Entrepreneurs

Our Entrepreneurs

We are proud to have been the capital partner to some of the most talented medtech teams in our industry. Our entrepreneurs have pioneered new treatments for chronic diseases, built entirely new commercial markets from the ground up, and ushered in the future of personalized medicine and connected care.

Acquired by Stryker

Acquired by Boston Scientific

Acquired by Edwards Lifesciences

Acquired by Wright Medical

Acquired by Alcon

Acquired by Covidien

IPO (NASDAQ: CVRX)

Acquired by Medtronic

IPO (NASDAQ: NARI)

Acquired by Philips

Acquired by CR Bard

Acquired by Johnson & Johnson

Acquired by Labcorp

Acquired by Boston Scientific

IPO (NYSE American: SENS)

Acquired by Terumo

Acquired by Abbott

Acquired by Merz

Acquired by Olympus

Acquired by Boston Scientific

Acquired by Philips

22

Novel FDA PMA & de novo 510k approvals

61

U.S. Commercial Product Launches

40

Level I Clinical Trials

34

Strategic Financings

31

Exits by IPO or M&A

VENSANA CAPITAL

CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS®

Ready to change healthcare together? Contact us to arrange for investments in development and commercial stage companies.

Get in Touch

Our Latest

See All News
Luna Diabetes Raises Series A Financing to Advance its Automated Insulin Delivery Solution For Insulin Pen Users
Vensana Capital Welcomes Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner
SpyGlass Pharma Raises $75 Million Series D Funding to Advance Its Long-term Drug Delivery Platform for Glaucoma Patients
Resources
News LP Access
Contact
[email protected] 612.217.8680
Engage
Minneapolis
Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435
Washington, D.C.
Vensana Capital 7900 Tysons One Place Suite 320 McLean, VA 22102

© 2025 Vensana Capital Management, LLC | Privacy | Terms & Conditions